A Case of Direct-Acting Oral Anticoagulant-Induced Intramural Colon Hematoma Successfully Treated by Laparoscopic Surgery.

Autor:	Tomita D; Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, JPN., Toda S; Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, JPN., Miyazaki R; Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, JPN., Matoba S; Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, JPN., Kuroyanagi H; Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, JPN.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2024 Apr 18; Vol. 16 (4), pp. e58513. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).
DOI:	10.7759/cureus.58513
Abstrakt:	Intramural intestinal hematoma is a rare disease, one of the triggering factors of which is the use of anticoagulants. In previous reports, most patients were on treatment with warfarin. Herein, we report a case of direct-acting oral anticoagulant (DOAC)-induced intramural hematoma of the ascending colon in a patient refractory to conservative treatment and required laparoscopic right hemicolectomy. An 80-year-old male patient with a history of atrial fibrillation and cerebral infarction, on treatment with apixaban, was brought to our hospital with the chief complaints of abdominal pain, vomiting, and melena. Imaging revealed the cause of symptoms to be intestinal obstruction caused by a mass lesion on the wall of the ascending colon. We initially opted for conservative treatment with discontinuation of apixaban and insertion of an ileus tube. Intestinal dilatation findings showed improvement; however, subsequent imaging examinations did not reveal the shrinkage of a lesion in the ascending colon. If the mass was not removed, recurrence of bowel obstruction symptoms was expected, so we decided to perform surgical intervention. A laparoscopic right hemicolectomy was performed, and an intramural hematoma of the ascending colon was diagnosed based on the excised specimen. He needed a blood transfusion for anemia but was discharged on postoperative day 14 with no other complications. DOACs are now widely used in patients with atrial fibrillation, and the risk of bleeding as a side effect is extremely low compared to conventional anticoagulants, including warfarin. However, when abdominal pain occurs, as in the present case, an intramural hematoma should be considered in the differential diagnosis. There is no established treatment plan for intestinal intramural hematoma. Although conservative treatment is effective in some cases, it is difficult to evaluate the risk of bleeding associated with DOACs using coagulation tests. Even if conservative treatment is selected, it is essential to determine surgical resection, if necessary, based on the clinical course and imaging and blood test findings. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Tomita et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu